Descripción de negocio
Perrigo Company plc, a top five global over-the-counter ("OTC") consumer goods and pharmaceutical company, offers patients and customers high quality products at affordable prices. From its beginnings in 1887 as a packager of generic home remedies, Perrigo, headquartered in Ireland, has grown to become the world's largest manufacturer of OTC products and supplier of infant formulas for the store brand market. The Company is also a leading provider of generic extended topical prescription products and receives royalties from Multiple Sclerosis drug Tysabri®. Perrigo provides Quality Affordable Healthcare Products® across a wide variety of product categories and geographies primarily in North America, Europe, and Australia, as well as other markets, including Israel, China and Latin America.
Consejo de gestión & Consejo de supervisión
| CEO |
| Murray S. Kessler |
| Consejo de gestión |
| Raymond Silcock, Grainne Quinn, James E. Dillard III, Rob Willis, Ron Janish, Svend Andersen, Todd W. Kingma, Tom Farrington |
| Consejo de supervisión |
| Rolf Classon, Adriana Karaboutis, Bradley Alford, Donal O'Connor, Erica L. Mann, Geoffrey M. Parker, Jeff Kindler, Katherine Doyle, Murray S. Kessler, Orlando D. Ashford, Theodore R. Samuels |
Datos de la empresa
| Nombre: |
Perrigo Company plc |
| Dirección: |
Treasury Building, Lower Grand Canal St.,IRL-Dublin 2, Ireland |
| Teléfono: |
+1-353-1709-4000 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.perrigo.com/ |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
67.70% |
| Fecha de OPI: |
- |
